Acute Myelogenous Leukemia Archives - Carevive - cancer care management & patient engagement tools

Intergrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults with AML to Drive Personalized Treatment Decisions

Posters Resources

Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults with AML to Drive Personalized Treatment Decisions

This project represents the first assessment of Oral Medication (OM) adherence in patients with AML.

CareviveDecember 15, 2021

Webinar - Acute Myelogenous Leukemia: Treatment Updates and

Resources

[On-Demand Video] Acute Myelogenous Leukemia: Treatment Updates and Implications for Older Patients

Note: This on-demand video is not available for CME/CNE credit. Acute myeloid leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit patients treated with intensive chemotherapy…

CareviveJuly 25, 2018